I think the biggest question at the moment is why haven't management been entirely transparent about this transaction?
There is a severe lack of material information about the EFS acquisition. It shouldn't be up to shareholders to try and fill in these information gaps. Surely, one would deem this missing information as market sensitive that requires disclosure so shareholders can make "informed decisions".
- Forums
- ASX - By Stock
- AQO
- Ann: Transforming New Standard Energy
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online